Welcome to the 3rd Gene Therapy Patient Engagement Summit
The role of patient engagement in gene therapy development is changing.
As the global healthcare system accelerates its acceptance of gene therapies as one-time, potentially curative, treatment options for rare diseases, the role of patient engagement in informing drug development strategy is evolving.
At this interface lies the 3rd Gene Therapy Patient Engagement Summit, uniting patient advocacy and engagement experts from leading gene therapy and gene editing drug developers, along with patient groups and patients themselves. Talks, workshops, and group discussions shed a light on how to better integrate the patient voice into gene therapy programs at crucial stages of the drug development process.
Our audience joined us in Boston this summer to gain the actionable insights, tools, and strategies needed to better implement patient input into patient-centric gene therapy programs.